Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. BioChem Sioux City Inc.
483
•BioChem Sioux City Inc.•August 6, 2021

FDA 483 - BioChem Sioux City Inc. - August 06, 2021

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

Aspen API, Inc. in Sioux City, Iowa, was inspected regarding its crude heparin manufacturing, revealing significant issues with contamination control and product quality. The firm failed to adequately protect Crude Heparin Sodium from contamination and allowed untrained employees to overrule critical product release decisions. Additionally, the inspection found deficiencies in testing procedures and the accuracy of Certificates of Analysis.

Company
BioChem Sioux City Inc.
Inspection Date
August 6, 2021
Product Type
Drugs
Office
Division of Human and Animal Food Operations - West II
People
  • Matthew M. Schuckmann
  • Matthew B. Casale ( Investigator )
Open in Dashboard

ID · 8cacec91-83aa-4431-af3e-1594777bb0cd

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.